ZNF233
Zinc finger protein 233
Also known as: FLJ38032, ZN233_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NK53
- Gene
- ZNF233
- Ensembl
- ENSG00000159915
- Chromosome
- 19
- Canonical length
- 670 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
670 residues, UniProt reviewed canonical sequence.
>A6NK53|ZNF233
1 MTKFQEMVTF KDVAVVFTRE ELGLLDLAQR KLYQDVMLEN FRNLLSVGYQ PFKLDVILQL
61 GKEDKLRMME TEIQGDGCSG HKNQNEIDTL QEVRLRFLSY EDLICWQIWE QFTSKLTSNQ
121 DLIINLQGKR SKLLKQGDSP CQVWTGESSQ VSEDENYVIK LQGESSNSIK NQELPLRTTW
181 DFWRKMYLRE PQNYQSRCQQ IDVKNKLCKC DHCVRQRIAH QHDDHGVHKR EKAFSHNNCG
241 KDCVKESSQH SIIQSGEQTS DENGKGLSVG SNLELHQQLH LRDKPHVNVE YGKGIGYSSG
301 LPRHQCFHIG EKCYRNGDSG EGFSQGSHLQ PHQRVSTGEN LYRCQVYARS SNQNSCLPSH
361 ELTHPGEKLC TCGRCGKGFH HSLDFDIHCV DSAGERACKC DVYDKGFSQT SQLQAHQRGH
421 SRDKTYKWEV SDRIFNRNSG LHQRVHTGEK PYKCEVCDKG FSKASNLQAH QRIHTGEKPY
481 KCDVCDKNFS RNSHLQAHQR VHTGEKPYKC DTCGKDFSQI SHLQAHQRVH KGEKPYKCET
541 CGKGFSQSSH LQDHQQVHTG ENPYKCDVCG KGFSWSSHLQ AHQRVHTGEK PYKCEECRKG
601 FIWNSYLHVH QRIHTGEKPY KCGMCGKSFS QTSHLQAHQR VHTGEKPYKC FVCGKGFSKS
661 SLSSDSSESPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF233 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- testis: 14 nTPM
- retina: 4.5 nTPM
- cerebral cortex: 3 nTPM
- heart muscle: 2.9 nTPM
- prostate: 2.6 nTPM
- thyroid gland: 1.8 nTPM
Single-cell type
- late primary spermatocytes: 97 nCPM
- cardiomyocytes: 57 nCPM
- epicardial cells: 46 nCPM
- early spermatids: 27 nCPM
- other brain neurons: 13 nCPM
- podocytes: 13 nCPM
Immune cell
- basophil: 1.4 nTPM
- naive B-cell: 1.3 nTPM
- plasmacytoid DC: 1.3 nTPM
- NK-cell: 1.1 nTPM
- memory B-cell: 0.8 nTPM
- naive CD8 T-cell: 0.7 nTPM
Brain region
- cerebellum: 36 nTPM
- cerebral cortex: 36 nTPM
- basal ganglia: 33 nTPM
- pons: 33 nTPM
- white matter: 33 nTPM
- hypothalamus: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF233 as an antibody target. Whether an autoantibody or antibody against ZNF233 could matter depends on whether native ZNF233 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF233 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF233 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...